NCT05180591View on ClinicalTrials.gov

Repeat BCG Vaccinations for the Treatment of Pediatric Type 1 Diabetes

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 22, 2022

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Diabetes Mellitus, Type 1Diabetes Type1Autoimmune Diabetes
Interventions
BIOLOGICAL

Bacillus Calmette-Guérin

2 BCG vaccinations spaced 4 weeks apart at the beginning of the trial

BIOLOGICAL

Saline Injection

2 BCG vaccinations spaced 4 weeks apart at the beginning of the trial

Trial Locations (1)

02129

RECRUITING

Immunobiology Labs CNY 149, Charlestown

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER